Latest Breaking News On - Liso cel therapy - Page 1 : comparemela.com

The indication is for adult patients who have received at least 2 prior lines of systemic therapy and is based on the response rate and duration of response shown in a phase 2 trial.

Bryan campbellBristol myers squibbInternational conference on malignant lymphomaCell therapyAdult subjects with relapsedRefractory indolentb cell non hodgkin lymphomaMalignant lymphomaCell therapy breyanzi approvedDrug administrationRefractory follicularLiso cel therapyAdult patients with